Long-term Effects of a Telemedically-assisted Lifestyle Intervention on Glycemic Control in Patients with Type 2 Diabetes - A Two-armed Randomised Controlled Trial in Germany
Overview
Authors
Affiliations
Purpose: Diabetes is considered one of the fastest growing diseases worldwide. Especially in the treatment of type 2 diabetes, lifestyle interventions have proven to be effective. However, long-term studies in real-world contexts are rare, which is why further research is needed. The aim of the present study is to investigate whether effects achieved in the context of a long-term lifestyle intervention can be sustained by patients in the long term.
Methods: In a two-arm randomized trial we compared diabetes care as usual to a lifestyle intervention combining telemedically support and individual needs-based telephone coaching. The study included 151 patients with type 2 diabetes randomized to either the intervention or control group. Intervention Group (IG; N = 86, 80.2% male, mean age: 59.7) received telemedical devices and telephone coaching over a period of 12 months, Control Group (CG; N = 65, 83.1% male, mean age: 58,8) received care as usual. The primary outcome was chance in Hb. A follow-up survey was conducted after 24 months.
Results: The intervention group showed significantly better HbA1c- values compared to the control group at both 12 and 24 months (12 M: - 0.52 (-0.73; - 0.32), p < .000; 24 M: - 0.38 (-0.61; - 0.15), p = .001). The strongest change was seen in the first three months, with the best value obtained at 6 months and stable thereafter.
Conclusion: Combined telephone coaching with telemedicine support could lead to better long-term glycemic control in people with type 2 diabetes. In the future, more long-term studies should be conducted in real-world settings and lifestyle interventions should be offered more widely.
Audio-Based Care for Managing Diabetes in Adults: A Systematic Review.
Reddy S, Booth G, Coker-Schwimmer M, Kugley S, Rodriguez-Borja I, Patel S Med Care. 2025; 63(2):152-163.
PMID: 39791848 PMC: 11708993. DOI: 10.1097/MLR.0000000000002096.
Zinn C, Campbell J, Po M, Saulilo L, Fraser L, Davies G J Diabetes Res. 2025; 2024:4843889.
PMID: 39741965 PMC: 11688139. DOI: 10.1155/jdr/4843889.
Dunkel A, von Storch K, Hochheim M, Zank S, Polidori M, Woopen C Int J Behav Med. 2024; 32(1):45-57.
PMID: 39349794 PMC: 11790748. DOI: 10.1007/s12529-024-10323-0.